0
points
0
points
1
0
1
0
points
0
points
1
0
1
The Glasgow-Blatchford Bleeding Score (GBS) is a validated clinical tool used to assess the severity of upper gastrointestinal (GI) bleeding and predict the need for clinical intervention such as blood transfusion, endoscopic therapy, or surgery. Developed by Blatchford and colleagues in 2000 at Glasgow Royal Infirmary, this scoring system has become one of the most widely used risk stratification tools in emergency medicine for patients presenting with hematemesis, melena, or other signs of upper GI hemorrhage.
The GBS evaluates both laboratory values and clinical features to generate a score ranging from 0 to 23. Laboratory parameters include blood urea nitrogen (BUN) and hemoglobin levels (with sex-specific thresholds), while clinical features include systolic blood pressure, pulse rate, presence of melena, syncope, hepatic disease, and heart failure. Each parameter is weighted according to its prognostic significance, with higher scores indicating greater severity and increased likelihood of requiring intervention.
One of the most clinically valuable features of the GBS is its ability to identify very low-risk patients. A score of 0 identifies patients who can be safely discharged for outpatient follow-up without the need for inpatient endoscopy or admission, potentially reducing unnecessary hospitalizations by up to 20%. This has been validated in multiple international studies and is now recommended by major gastroenterology guidelines including those from the National Institute for Health and Care Excellence (NICE) and the American College of Gastroenterology (ACG).
This calculator helps emergency physicians and gastroenterologists rapidly compute the GBS at the bedside, facilitating timely triage decisions. Patients with scores of 0 may be considered for safe outpatient management, while those with higher scores warrant urgent endoscopy, blood product support, and close hemodynamic monitoring in an inpatient setting.
The Glasgow-Blatchford Score sums weighted points from the following parameters:
Blood Urea Nitrogen: <18.2 mg/dL = 0; 18.2–22.3 = +2; 22.4–27.9 = +3; 28.0–69.9 = +4; ≥70 = +6
Hemoglobin (Male): ≥13.0 g/dL = 0; 12.0–12.9 = +1; 10.0–11.9 = +3; <10.0 = +6
Hemoglobin (Female): ≥12.0 g/dL = 0; 10.0–11.9 = +1; <10.0 = +6
Systolic BP: ≥110 mmHg = 0; 100–109 = +1; 90–99 = +2; <90 = +3
Other markers: Pulse ≥100 = +1; Melena = +1; Syncope = +2; Hepatic disease = +2; Heart failure = +2
Total score ranges from 0 to 23. A score of 0 identifies patients at very low risk who may be safely managed as outpatients.
A GBS of 0 identifies very low-risk patients with virtually no need for clinical intervention — these patients may be safely discharged with outpatient follow-up. Scores of 1–5 indicate moderate risk requiring admission and likely endoscopy. Scores of 6 or higher indicate high-risk bleeding with significant potential for requiring blood transfusion, endoscopic intervention, or surgery. Higher scores correlate with longer hospital stays, ICU admission, and increased mortality.
Inputs
Results
GBS = 0 — patient can be considered for outpatient management.
Inputs
Results
GBS = 13 — high risk, requires urgent endoscopy and likely transfusion.
The Glasgow-Blatchford Score is a clinical scoring system that predicts the need for medical intervention in patients with upper gastrointestinal bleeding using laboratory values (BUN, hemoglobin) and clinical features (blood pressure, pulse, melena, syncope, comorbidities).
Yes. Multiple validation studies have confirmed that patients with a GBS of 0 have an extremely low risk of requiring intervention and can be safely discharged for outpatient follow-up, with a negative predictive value exceeding 99%.
The maximum GBS is 23 points, indicating the most severe presentation with high BUN, severely low hemoglobin, hemodynamic instability, and multiple adverse clinical features.
GBS is better at predicting the need for intervention, while the Rockall Score (which includes endoscopic findings) is better at predicting mortality. GBS can be calculated pre-endoscopy, making it more useful for initial triage.
Men and women have different normal hemoglobin ranges. Male hemoglobin thresholds start higher (13 g/dL) because men normally have higher hemoglobin levels. Using sex-specific cutoffs improves the diagnostic accuracy of the score.
No. The GBS is entirely a pre-endoscopic score, meaning it can be calculated immediately in the emergency department using routine labs and clinical assessment, without waiting for endoscopy results.
GBS predicts the need for blood transfusion, endoscopic therapy (injection, clipping, thermal coagulation), surgery, or any clinical intervention beyond supportive care for upper GI bleeding.
Melena (dark, tarry stools) is a scored criterion worth 1 point. Hematemesis itself is not directly scored but is implied by the clinical presentation of upper GI bleeding that prompts score calculation.
Yes. International guidelines recommend calculating GBS for all patients presenting with suspected upper GI bleeding to guide triage decisions, particularly to identify low-risk patients suitable for outpatient management.
No. GBS was developed and validated specifically for upper gastrointestinal bleeding (above the ligament of Treitz). Different scoring systems are used for lower GI bleeding assessment.
Roboculator Team
The Roboculator Team explains calculations, planning tools, and practical formulas in clear language for real-life situations.
How helpful was this calculator?
Be the first to rate!
